(Q41596889)

4 October 2017

title

Accelerated atherosclerosis and coronary disease in SLE. (English)

1 reference

4 October 2017

Y Farhey

1

1 reference

4 October 2017

E V Hess

series ordinal

2

1 reference

4 October 2017

publication date

1 January 1997

1 reference

4 October 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Lupus

1 reference

4 October 2017

volume

6

1 reference

4 October 2017

issue

7

1 reference

4 October 2017

page(s)

572-577

1 reference

Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Is atherosclerosis an immunologically mediated disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Corticosteroids: do they damage the cardiovascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Central obesity and coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Fibrinogen synthesis in serum-free hepatocyte cultures: Stimulation by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339700600704

10.1177/096120339700600704

21 January 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference